However, in individuals with obesity and diabetes, impaired GLP-1 secretion or function contributes to increased appetite, fat accumulation, and disrupted energy metabolism, further exacerbating obesity and insulin resistance (Guardado Mendoza et al., 2015; Derbenev and Zsombok, 2016). Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.